COLGATE PALMOLIVE Q1 FY25 earnings call CL

The company observed a significant slowdown in category growth in February across its categories, particularly in the U.S., attributed to macroeconomic and consumer uncertainty^🌐. While half of the categories showed sequential improvement in March, and further improvement was noted in April, the market is not yet fully recovered. Management expects Q2 to remain soft but anticipates normalization in categories towards the back half of the year as consumer confidence potentially returns. The strategy focuses on daily use products, expecting consumers to return after pantry deloading and modest retailer destocking.

Colgate-Palmolive has built flexibility into its plans to adapt to the volatile environment. This includes fine-tuning promotional strategies to offer value across price tiers and leveraging geographic breadth to mitigate single-market exposure. The company emphasizes continued investment in brand health, innovation (like Colgate Total and Hill's Science Diet with ActivBiome+ Technology), and capabilities such as AI and data analytics. The strong P&L and balance sheet are seen as advantages enabling sustained investment and growth.

Pricing in Q1 was in line with expectations and improved sequentially on a two-year stack basis, despite difficult comparisons. Pricing adjustments made in late FY24 are flowing through in H1 FY25, with improvements expected in H2. The company is implementing new pricing in Latin America (Mexico, Brazil) for Q2/Q3/Q4. Europe's strong performance is linked to premium innovation and improved mix. The company utilizes AI for better diagnosis and predictability of promotions and pricing, aiming for value creation through innovation rather than aggressive promotion.

Hill's Pet Nutrition delivered strong organic growth of 5% ex-private label in Q1, significantly outperforming a flat category. This growth was broad-based across wet, dry, treats, cat, dog, prescription, and science diets. The business also saw a substantial margin improvement of approximately 450 basis points, driven by efficiency, productivity, pricing, and premium innovation. The strategy focuses on capturing growth in under-indexed segments like wet food and cat food, bringing value to retailers and increasing brand penetration.

The company has invested approximately $2 billion in its U.S. supply chain over the past five years, increasing U.S.-based manufacturing facilities by over 40%. This has built flexibility and reduced reliance on single-source countries, particularly China. To mitigate the $200 million incremental tariff impact^🌐, Colgate-Palmolive plans a combination of productivity initiatives, accelerated Funding-the-Growth opportunities, increased premiumization through innovation, and revenue growth management. The impact of tariffs is included in the full-year gross profit margin guidance of roughly flat.

North America experienced a negative 3% organic sales growth in Q1, primarily due to volume weakness, lower store traffic, and conversion. The company is implementing a sharpened strategy focusing on innovation, price-pack architecture, productivity, and advertising ROI, expecting improvements in the back half. In emerging markets, while China (Hawley & Hazel) and India's urban markets remain soft, other regions like Philippines, Thailand, and most of Africa (excluding South Africa and Turkey) showed balanced growth. Latin America, despite some Q1 softness, is expected to improve in H2 given strong market shares and innovation pipeline.